METOPROLOL TARTRATE

METOPROLOL TARTRATE was reported 275108 times

METOPROLOL TARTRATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BRASH SYNDROME 616 0.4387
1 EJECTION FRACTION 232 0.3993
2 SENSITISATION 254 0.3347
3 NEPHROGENIC ANAEMIA 1014 0.2187
4 HYPERPARATHYROIDISM SECONDARY 532 0.2121
5 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 223 0.2100
6 PRODUCT MONITORING ERROR 276 0.1910
7 POLYCYSTIC OVARIES 250 0.1611
8 HYPERTENSIVE EMERGENCY 169 0.1433
9 REBOUND ACID HYPERSECRETION 415 0.1371
10 END STAGE RENAL DISEASE 2146 0.1175
11 ESSENTIAL HYPERTENSION 198 0.1081
12 HAEMORRHAGIC ANAEMIA 470 0.1068
13 NEPHROGENIC SYSTEMIC FIBROSIS 257 0.0850
14 ATRIAL FLUTTER 677 0.0848
15 ANGINA UNSTABLE 546 0.0839
16 CORONARY ARTERY BYPASS 471 0.0818
17 CORONARY ARTERY DISEASE 2450 0.0808
18 CORONARY ARTERY STENOSIS 390 0.0775
19 ATRIAL FIBRILLATION 7543 0.0774
20 ATRIOVENTRICULAR BLOCK FIRST DEGREE 334 0.0770
21 RHINITIS ALLERGIC 339 0.0761
22 CORONARY ARTERY OCCLUSION 1021 0.0744
23 ISCHAEMIC CARDIOMYOPATHY 227 0.0740
24 CHRONIC KIDNEY DISEASE 5617 0.0739
25 AORTIC STENOSIS 253 0.0726
26 ORTHOPNOEA 230 0.0721
27 DIASTOLIC DYSFUNCTION 215 0.0696
28 CORONARY ARTERIAL STENT INSERTION 353 0.0696
29 BLOOD PRESSURE DIASTOLIC ABNORMAL 175 0.0687
30 SUSPECTED SUICIDE 322 0.0686
31 LOWER GASTROINTESTINAL HAEMORRHAGE 507 0.0685
32 AORTIC ARTERIOSCLEROSIS 175 0.0679
33 TACHYARRHYTHMIA 168 0.0673
34 HEART VALVE INCOMPETENCE 192 0.0669
35 ACUTE MYOCARDIAL INFARCTION 1955 0.0662
36 SINUS BRADYCARDIA 639 0.0660
37 LEFT VENTRICULAR HYPERTROPHY 279 0.0651
38 BRADYCARDIA 3455 0.0651
39 MITRAL VALVE INCOMPETENCE 737 0.0650
40 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 570 0.0644
41 ARTERIOSCLEROSIS CORONARY ARTERY 421 0.0635
42 VENTRICULAR HYPOKINESIA 203 0.0631
43 AORTIC VALVE INCOMPETENCE 266 0.0625
44 CARDIAC FAILURE CHRONIC 262 0.0614
45 VASCULAR GRAFT 176 0.0610
46 FIBROSIS 186 0.0604
47 RENAL INJURY 1782 0.0599
48 ATRIOVENTRICULAR BLOCK COMPLETE 399 0.0596
49 CARDIAC FAILURE CONGESTIVE 4758 0.0592
50 CARDIOGENIC SHOCK 849 0.0591
51 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 241 0.0590
52 SUPRAVENTRICULAR EXTRASYSTOLES 199 0.0589
53 VENTRICULAR TACHYCARDIA 964 0.0583
54 ATRIOVENTRICULAR BLOCK 448 0.0579
55 CAROTID ARTERY STENOSIS 202 0.0578
56 BUNDLE BRANCH BLOCK LEFT 245 0.0577
57 HYPOVOLAEMIA 338 0.0577
58 TRICUSPID VALVE INCOMPETENCE 456 0.0573
59 ACUTE CORONARY SYNDROME 466 0.0562
60 CARDIAC VALVE DISEASE 319 0.0557
61 HYPERLIPIDAEMIA 665 0.0556
62 LEFT VENTRICULAR FAILURE 191 0.0554
63 SUPRAVENTRICULAR TACHYCARDIA 530 0.0553
64 VENTRICULAR EXTRASYSTOLES 572 0.0550
65 INTERNATIONAL NORMALISED RATIO DECREASED 221 0.0545
66 ARTERIOSCLEROSIS 512 0.0543
67 PERIPHERAL VASCULAR DISORDER 277 0.0537
68 RENAL CYST 423 0.0532
69 ANGINA PECTORIS 1526 0.0532
70 UPPER GASTROINTESTINAL HAEMORRHAGE 889 0.0528
71 TROPONIN INCREASED 402 0.0528
72 DIVERTICULUM 374 0.0526
73 HEART RATE DECREASED 1833 0.0521
74 BLOOD PRESSURE INADEQUATELY CONTROLLED 314 0.0521
75 GOUT 933 0.0519
76 PROSTATOMEGALY 204 0.0519
77 RENAL FAILURE CHRONIC 399 0.0518
78 HAEMORRHOIDAL HAEMORRHAGE 246 0.0503
79 CAROTID ARTERY OCCLUSION 182 0.0498
80 DIVERTICULUM INTESTINAL 217 0.0496
81 LEFT VENTRICULAR DYSFUNCTION 331 0.0494
82 CARDIOMEGALY 603 0.0490
83 ATELECTASIS 473 0.0489
84 HEART RATE IRREGULAR 1104 0.0488
85 VENTRICULAR ARRHYTHMIA 178 0.0486
86 BLOOD PRESSURE DIASTOLIC DECREASED 359 0.0486
87 SLEEP APNOEA SYNDROME 928 0.0486
88 BLOOD PRESSURE SYSTOLIC DECREASED 221 0.0485
89 BODY HEIGHT DECREASED 517 0.0483
90 DIABETIC NEUROPATHY 239 0.0482
91 NEPHROPATHY 449 0.0480
92 ARTERIAL OCCLUSIVE DISEASE 377 0.0479
93 INTERNATIONAL NORMALISED RATIO INCREASED 1365 0.0478
94 EJECTION FRACTION DECREASED 743 0.0478
95 BLOOD PRESSURE SYSTOLIC INCREASED 931 0.0477
96 HEART RATE ABNORMAL 266 0.0477
97 HIATUS HERNIA 616 0.0475
98 INTERNAL HAEMORRHAGE 542 0.0474
99 RENAL FAILURE 6291 0.0473
100 DYSLIPIDAEMIA 238 0.0468
101 HYPERKALAEMIA 1623 0.0462
102 DYSPNOEA EXERTIONAL 1731 0.0459
103 PATENT DUCTUS ARTERIOSUS 182 0.0458
104 CARDIAC PACEMAKER INSERTION 272 0.0456
105 CATHETERISATION CARDIAC 202 0.0455
106 BLOOD MAGNESIUM DECREASED 393 0.0455
107 ACUTE KIDNEY INJURY 6966 0.0455
108 MYOCARDIAL ISCHAEMIA 518 0.0455
109 COAGULOPATHY 747 0.0448
110 GASTROINTESTINAL HAEMORRHAGE 3732 0.0446
111 STENT PLACEMENT 358 0.0444
112 RALES 257 0.0442
113 BODY TEMPERATURE DECREASED 435 0.0441
114 GLUCOSE TOLERANCE IMPAIRED 260 0.0439
115 SPINAL OSTEOARTHRITIS 386 0.0439
116 COMPLETED SUICIDE 3656 0.0438
117 ACUTE RESPIRATORY FAILURE 839 0.0436
118 BLOOD POTASSIUM INCREASED 708 0.0436
119 BUNDLE BRANCH BLOCK RIGHT 200 0.0435
120 HYPERTENSIVE CRISIS 484 0.0435
121 SPINAL COLUMN STENOSIS 203 0.0429
122 HYPERVOLAEMIA 211 0.0427
123 HYPOTENSION 8476 0.0422
124 VENTRICULAR FIBRILLATION 468 0.0421
125 MYOCARDIAL INFARCTION 7349 0.0421
126 EXERCISE TOLERANCE DECREASED 241 0.0418
127 PULSELESS ELECTRICAL ACTIVITY 174 0.0416
128 BLOOD TEST ABNORMAL 585 0.0416
129 HAIR DISORDER 343 0.0416
130 DIZZINESS POSTURAL 402 0.0414
131 CARPAL TUNNEL SYNDROME 579 0.0413
132 CARDIAC FAILURE ACUTE 275 0.0412
133 GLOMERULAR FILTRATION RATE DECREASED 507 0.0412
134 ORTHOSTATIC HYPOTENSION 713 0.0409
135 BLOOD CREATINE INCREASED 181 0.0408
136 HAEMORRHAGIC STROKE 319 0.0408
137 BLOOD URINE PRESENT 772 0.0406
138 BLOOD PRESSURE FLUCTUATION 974 0.0405
139 ELECTROLYTE IMBALANCE 471 0.0405
140 CARDIAC FLUTTER 262 0.0405
141 ELECTROCARDIOGRAM ABNORMAL 317 0.0404
142 RENAL TUBULAR NECROSIS 395 0.0402
143 INTERVERTEBRAL DISC DEGENERATION 372 0.0402
144 EXTRASYSTOLES 280 0.0401
145 AORTIC ANEURYSM 304 0.0399
146 PROTHROMBIN TIME PROLONGED 238 0.0398
147 BLOOD UREA INCREASED 666 0.0397
148 BENIGN PROSTATIC HYPERPLASIA 204 0.0395
149 RENAL FAILURE ACUTE 1673 0.0394
150 SKIN ABRASION 186 0.0393
151 ECCHYMOSIS 269 0.0392
152 PRODUCT PRESCRIBING ERROR 934 0.0392
153 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 200 0.0390
154 HAEMATOCRIT DECREASED 773 0.0389
155 PSYCHOLOGICAL TRAUMA 336 0.0389
156 PULSE ABSENT 185 0.0389
157 IRON DEFICIENCY ANAEMIA 357 0.0386
158 MENTAL STATUS CHANGES 1074 0.0386
159 CARDIOMYOPATHY 564 0.0381
160 ANEURYSM 189 0.0379
161 HAEMATOMA 976 0.0376
162 WEIGHT FLUCTUATION 392 0.0374
163 HAEMATURIA 1283 0.0374
164 ARRHYTHMIA 1772 0.0374
165 LUNG INFILTRATION 330 0.0373
166 RENAL FUNCTION TEST ABNORMAL 173 0.0372
167 PULMONARY OEDEMA 1658 0.0370
168 PULMONARY HYPERTENSION 768 0.0368
169 SYNCOPE 3689 0.0368
170 HAIR COLOUR CHANGES 458 0.0368
171 CLOSTRIDIUM DIFFICILE COLITIS 390 0.0367
172 HEPARIN-INDUCED THROMBOCYTOPENIA 181 0.0367
173 INCREASED TENDENCY TO BRUISE 337 0.0366
174 HYPOMAGNESAEMIA 509 0.0365
175 ECONOMIC PROBLEM 554 0.0365
176 CARDIAC MURMUR 315 0.0364
177 TUBULOINTERSTITIAL NEPHRITIS 682 0.0364
178 ANHEDONIA 956 0.0363
179 FLANK PAIN 341 0.0363
180 MULTIPLE INJURIES 229 0.0363
181 BLOOD SODIUM DECREASED 685 0.0363
182 TORSADE DE POINTES 285 0.0363
183 ATRIAL SEPTAL DEFECT 304 0.0363
184 BLOOD PRESSURE DIASTOLIC INCREASED 167 0.0361
185 URINE OUTPUT DECREASED 313 0.0358
186 TRANSIENT ISCHAEMIC ATTACK 1206 0.0357
187 BREATH SOUNDS ABNORMAL 176 0.0357
188 UROSEPSIS 329 0.0356
189 PRESYNCOPE 866 0.0356
190 BLOOD POTASSIUM DECREASED 1063 0.0353
191 BLOOD ALBUMIN DECREASED 280 0.0353
192 BLOOD PRESSURE INCREASED 5388 0.0352
193 RECTAL HAEMORRHAGE 1506 0.0350
194 PLEURAL EFFUSION 2133 0.0350
195 SMALL FOR DATES BABY 174 0.0350
196 KIDNEY TRANSPLANT REJECTION 168 0.0350
197 BLOOD CREATININE INCREASED 2285 0.0350
198 OEDEMA PERIPHERAL 4258 0.0349
199 HYPOKALAEMIA 1609 0.0348
200 HYPERKERATOSIS 192 0.0348
201 OSTEOARTHRITIS 1469 0.0346
202 SUBDURAL HAEMATOMA 496 0.0346
203 MYOPATHY 297 0.0344
204 HEART RATE INCREASED 3392 0.0342
205 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1783 0.0341
206 IMPAIRED GASTRIC EMPTYING 465 0.0341
207 HAIR TEXTURE ABNORMAL 455 0.0340
208 DEHYDRATION 4537 0.0340
209 HAEMATOCHEZIA 1868 0.0338
210 RHABDOMYOLYSIS 1406 0.0337
211 UNRESPONSIVE TO STIMULI 869 0.0336
212 LACERATION 316 0.0336
213 FLUID OVERLOAD 487 0.0334
214 POLYP 219 0.0334
215 HAEMOGLOBIN DECREASED 3430 0.0334
216 BLOOD PRESSURE DECREASED 2218 0.0333
217 PULMONARY CONGESTION 440 0.0333
218 CARDIAC DISORDER 3117 0.0333
219 MELAENA 731 0.0332
220 CARDIAC OPERATION 284 0.0330
221 BLOOD PRESSURE ABNORMAL 656 0.0330
222 SINUS TACHYCARDIA 468 0.0329
223 LARGE INTESTINE POLYP 228 0.0329
224 NOCTURIA 399 0.0328
225 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 166 0.0328
226 BLOOD IRON DECREASED 389 0.0327
227 ENDOCARDITIS 168 0.0327
228 HOSPICE CARE 323 0.0327
229 GASTRIC ULCER HAEMORRHAGE 181 0.0326
230 HYPERTENSION 6892 0.0325
231 POST PROCEDURAL HAEMORRHAGE 378 0.0324
232 CARDIAC FAILURE 2597 0.0323
233 CHEST PAIN 5969 0.0322
234 MULTI-ORGAN FAILURE 555 0.0321
235 FAILURE TO THRIVE 166 0.0319
236 SUBARACHNOID HAEMORRHAGE 325 0.0319
237 HAEMODYNAMIC INSTABILITY 243 0.0319
238 CIRCULATORY COLLAPSE 543 0.0319
239 FAECES DISCOLOURED 689 0.0317
240 ULCER HAEMORRHAGE 215 0.0317
241 GENERAL PHYSICAL HEALTH DETERIORATION 3667 0.0317
242 EPISTAXIS 2363 0.0316
243 VITAMIN D DEFICIENCY 308 0.0316
244 DRUG INTERACTION 5010 0.0315
245 PERICARDIAL EFFUSION 730 0.0315
246 GASTROOESOPHAGEAL REFLUX DISEASE 2538 0.0315
247 POLYURIA 258 0.0315
248 RENAL IMPAIRMENT 2644 0.0314
249 ORAL PAIN 704 0.0314
250 BLOOD URIC ACID INCREASED 181 0.0313
251 HEPATIC STEATOSIS 583 0.0313
252 PULMONARY MASS 466 0.0313
253 DRUG LEVEL INCREASED 517 0.0312
254 URINE ODOUR ABNORMAL 183 0.0311
255 FLUID RETENTION 1579 0.0310
256 HYPOXIA 1093 0.0310
257 CARDIAC ARREST 2561 0.0310
258 METABOLIC ACIDOSIS 989 0.0309
259 LOCALISED INFECTION 744 0.0307
260 ACIDOSIS 235 0.0307
261 TRANSFUSION 320 0.0305
262 ACUTE PULMONARY OEDEMA 171 0.0304
263 FALL 10097 0.0303
264 HAEMORRHAGE INTRACRANIAL 453 0.0303
265 PRE-EXISTING CONDITION IMPROVED 189 0.0302
266 DIVERTICULITIS 838 0.0302
267 RIB FRACTURE 621 0.0302
268 DUODENAL ULCER 212 0.0300
269 HYPERCHOLESTEROLAEMIA 290 0.0300
270 ANAEMIA 5714 0.0299
271 SKIN LACERATION 325 0.0299
272 CONTUSION 2872 0.0298
273 PROSTATIC SPECIFIC ANTIGEN INCREASED 410 0.0297
274 MADAROSIS 345 0.0297
275 RENAL DISORDER 1383 0.0297
276 HYPOTHYROIDISM 944 0.0295
277 HAEMOPTYSIS 824 0.0295
278 DECUBITUS ULCER 240 0.0294
279 FEAR 791 0.0294
280 CHOLELITHIASIS 962 0.0293
281 PURPURA 259 0.0292
282 GASTRIC ULCER 552 0.0290
283 BLOOD COUNT ABNORMAL 440 0.0290
284 SMALL INTESTINAL OBSTRUCTION 356 0.0289
285 RED BLOOD CELL COUNT DECREASED 826 0.0289
286 HYPERTHYROIDISM 418 0.0288
287 CELLULITIS 1450 0.0287
288 BLOOD TRIGLYCERIDES INCREASED 508 0.0287
289 DECREASED ACTIVITY 310 0.0287
290 HEAD INJURY 908 0.0287
291 LACTIC ACIDOSIS 929 0.0287
292 PELVIC FRACTURE 223 0.0286
293 DYSURIA 1054 0.0286
294 LYMPHOEDEMA 198 0.0286
295 MUSCULOSKELETAL PAIN 1498 0.0286
296 FULL BLOOD COUNT DECREASED 576 0.0286
297 GROIN PAIN 251 0.0286
298 HAEMORRHOIDS 557 0.0285
299 PERIPHERAL COLDNESS 392 0.0285
300 BLOOD CALCIUM DECREASED 321 0.0285
301 WALKING AID USER 188 0.0285
302 CEREBRAL HAEMORRHAGE 1018 0.0284
303 GASTRITIS 748 0.0284
304 SHOCK HAEMORRHAGIC 231 0.0283
305 ROTATOR CUFF SYNDROME 364 0.0283
306 MENISCUS INJURY 174 0.0283
307 SCIATICA 451 0.0283
308 OBESITY 450 0.0282
309 RESPIRATORY FAILURE 2057 0.0282
310 BASAL CELL CARCINOMA 439 0.0281
311 ASTHENIA 10573 0.0281
312 MUSCULOSKELETAL CHEST PAIN 435 0.0281
313 HYPONATRAEMIA 1580 0.0280
314 DYSPNOEA 15819 0.0279
315 SCOLIOSIS 173 0.0279
316 URINARY TRACT INFECTION 4760 0.0279
317 HAEMODIALYSIS 234 0.0278
318 OSTEOPENIA 422 0.0278
319 SKIN ULCER 717 0.0277
320 HIP FRACTURE 892 0.0277
321 ABNORMAL LOSS OF WEIGHT 189 0.0277
322 HYPOGLYCAEMIA 1342 0.0276
323 POLLAKIURIA 1153 0.0276
324 OESOPHAGITIS 302 0.0276
325 LIMB INJURY 750 0.0276
326 LEUKOCYTOSIS 499 0.0275
327 VITAMIN D DECREASED 234 0.0273
328 PERIPHERAL SWELLING 4215 0.0273
329 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 464 0.0273
330 EYE HAEMORRHAGE 364 0.0272
331 ISCHAEMIC STROKE 486 0.0272
332 PLATELET COUNT INCREASED 355 0.0272
333 CHROMATURIA 611 0.0270
334 DIABETES MELLITUS INADEQUATE CONTROL 479 0.0270
335 MACULAR DEGENERATION 323 0.0270
336 FLUSHING 2749 0.0270
337 HYPERGLYCAEMIA 983 0.0269
338 HAEMOGLOBIN ABNORMAL 173 0.0269
339 PALPITATIONS 3141 0.0268
340 TOOTH ABSCESS 272 0.0267
341 NERVE COMPRESSION 246 0.0266
342 INTERVERTEBRAL DISC PROTRUSION 582 0.0266
343 SPLENOMEGALY 311 0.0265
344 GINGIVAL BLEEDING 362 0.0265
345 HYPOPHAGIA 673 0.0263
346 TACHYCARDIA 2329 0.0262
347 CATARACT 1560 0.0262
348 GENERALISED OEDEMA 324 0.0262
349 EMPHYSEMA 264 0.0261
350 PETECHIAE 273 0.0261
351 FIBROMYALGIA 635 0.0261
352 DIZZINESS 13027 0.0261
353 INCONTINENCE 276 0.0261
354 BOWEL MOVEMENT IRREGULARITY 199 0.0260
355 CYSTITIS 827 0.0259
356 SHOCK 597 0.0259
357 CLOSTRIDIUM DIFFICILE INFECTION 566 0.0259
358 HEMIPARESIS 439 0.0259
359 HYPOTHERMIA 262 0.0259
360 FAECES SOFT 188 0.0258
361 EXOSTOSIS 236 0.0258
362 BALANCE DISORDER 2232 0.0258
363 PRODUCTIVE COUGH 1231 0.0258
364 MOUTH HAEMORRHAGE 189 0.0258
365 MALNUTRITION 288 0.0257
366 OXYGEN SATURATION DECREASED 1445 0.0257
367 FULL BLOOD COUNT ABNORMAL 271 0.0256
368 PALLOR 697 0.0256
369 DRUG PRESCRIBING ERROR 492 0.0256
370 FLATULENCE 1450 0.0255
371 WEIGHT DECREASED 7137 0.0255
372 CEREBROVASCULAR ACCIDENT 4325 0.0255
373 SEPSIS 2847 0.0255
374 JOINT EFFUSION 176 0.0255
375 DEMENTIA 713 0.0255
376 SEASONAL ALLERGY 361 0.0255
377 JOINT RANGE OF MOTION DECREASED 340 0.0253
378 MUSCULAR WEAKNESS 2876 0.0253
379 DYSSTASIA 738 0.0252
380 RIGHT VENTRICULAR FAILURE 177 0.0252
381 PULMONARY THROMBOSIS 275 0.0252
382 MUSCLE STRAIN 217 0.0251
383 WHITE BLOOD CELL COUNT INCREASED 959 0.0250
384 BURSITIS 303 0.0249
385 DIALYSIS 354 0.0249
386 PNEUMONIA 8063 0.0249
387 ARTHRITIS 1958 0.0249
388 DECREASED APPETITE 5778 0.0249
389 OEDEMA 1349 0.0248
390 TYPE 2 DIABETES MELLITUS 837 0.0248
391 ASPIRATION 272 0.0248
392 HAEMATEMESIS 629 0.0248
393 POOR QUALITY SLEEP 534 0.0248
394 SPINAL COMPRESSION FRACTURE 205 0.0248
395 OSTEOPOROSIS 1019 0.0247
396 CARDIO-RESPIRATORY ARREST 1035 0.0247
397 BONE DISORDER 450 0.0247
398 HALLUCINATION, VISUAL 520 0.0246
399 BRONCHITIS 1819 0.0245
400 ANAL INCONTINENCE 221 0.0245
401 INITIAL INSOMNIA 251 0.0244
402 TASTE DISORDER 496 0.0244
403 RESPIRATORY RATE INCREASED 217 0.0244
404 CHEST DISCOMFORT 2500 0.0244
405 DELIRIUM 846 0.0244
406 ENCEPHALOPATHY 598 0.0243
407 AGEUSIA 607 0.0243
408 URINARY INCONTINENCE 720 0.0243
409 RETCHING 518 0.0243
410 LOW DENSITY LIPOPROTEIN INCREASED 187 0.0241
411 URINARY RETENTION 805 0.0241
412 HEPATOMEGALY 237 0.0241
413 BACK DISORDER 391 0.0240
414 STAPHYLOCOCCAL INFECTION 792 0.0240
415 GINGIVAL PAIN 191 0.0240
416 BLOOD CHOLESTEROL INCREASED 1118 0.0240
417 DYSPEPSIA 2359 0.0240
418 WOUND 670 0.0239
419 UPPER-AIRWAY COUGH SYNDROME 197 0.0239
420 HYDRONEPHROSIS 179 0.0239
421 TOOTH INFECTION 315 0.0239
422 CONSTIPATION 5206 0.0238
423 GAIT DISTURBANCE 4558 0.0238
424 DYSPHONIA 1389 0.0237
425 WRIST FRACTURE 284 0.0237
426 DENTAL CARIES 262 0.0237
427 COUGH 6641 0.0237
428 POST PROCEDURAL COMPLICATION 454 0.0236
429 BLOOD DISORDER 189 0.0236
430 DIARRHOEA 15201 0.0235
431 TACHYPNOEA 320 0.0235
432 DIABETES MELLITUS 1793 0.0235
433 HYPOCALCAEMIA 445 0.0235
434 WHEEZING 1394 0.0235
435 BLOOD CALCIUM INCREASED 206 0.0235
436 SQUAMOUS CELL CARCINOMA 221 0.0235
437 MUSCULOSKELETAL DISCOMFORT 404 0.0234
438 FOOT FRACTURE 445 0.0234
439 MICTURITION URGENCY 268 0.0234
440 HYPERSOMNIA 672 0.0234
441 ABNORMAL FAECES 192 0.0234
442 CONFUSIONAL STATE 3786 0.0234
443 TENDERNESS 244 0.0234
444 TOOTH FRACTURE 258 0.0234
445 TOOTH DISORDER 518 0.0233
446 ERUCTATION 450 0.0232
447 THROMBOSIS 1871 0.0232
448 BACTERAEMIA 276 0.0232
449 HYPOTONIA 231 0.0231
450 UPPER LIMB FRACTURE 461 0.0231
451 NEPHROLITHIASIS 1060 0.0231
452 GASTROENTERITIS 337 0.0231
453 PLATELET COUNT DECREASED 2455 0.0230
454 OSTEOMYELITIS 417 0.0230
455 COLD SWEAT 403 0.0228
456 HALLUCINATION 1718 0.0228
457 BACK PAIN 5291 0.0228
458 ANURIA 196 0.0228
459 FATIGUE 17725 0.0227
460 LIGAMENT SPRAIN 225 0.0227
461 RESTLESS LEGS SYNDROME 411 0.0226
462 CHOLECYSTITIS 269 0.0226
463 EATING DISORDER 480 0.0225
464 COVID-19 PNEUMONIA 266 0.0225
465 FACIAL PAIN 201 0.0225
466 EAR DISCOMFORT 230 0.0224
467 DYSARTHRIA 843 0.0224
468 DEEP VEIN THROMBOSIS 1455 0.0224
469 DRY MOUTH 1814 0.0223
470 POLYNEUROPATHY 267 0.0223
471 BLADDER DISORDER 221 0.0222
472 NEURALGIA 541 0.0222
473 SCAB 253 0.0222
474 ADRENAL INSUFFICIENCY 269 0.0221
475 PAIN IN EXTREMITY 6528 0.0221
476 SKIN DISCOLOURATION 1016 0.0221
477 FEELING HOT 1355 0.0221
478 LETHARGY 1270 0.0221
479 TOXICITY TO VARIOUS AGENTS 3714 0.0220
480 ELECTROCARDIOGRAM QT PROLONGED 792 0.0220
481 APHASIA 663 0.0219
482 HERNIA 424 0.0219
483 ANKLE FRACTURE 339 0.0219
484 MASS 306 0.0219
485 NECK PAIN 1223 0.0219
486 MUSCLE ATROPHY 277 0.0218
487 LOSS OF CONSCIOUSNESS 2801 0.0218
488 SPUTUM DISCOLOURED 207 0.0218
489 LIMB DISCOMFORT 675 0.0218
490 SINUS DISORDER 432 0.0218
491 FEELING COLD 605 0.0217
492 DISORIENTATION 861 0.0217
493 BACK INJURY 236 0.0217
494 HYPOKINESIA 315 0.0217
495 WOUND INFECTION 237 0.0216
496 UPPER RESPIRATORY TRACT INFECTION 997 0.0216
497 HYPERHIDROSIS 2777 0.0215
498 TOOTHACHE 390 0.0215
499 SINUS CONGESTION 291 0.0215
500 SKIN HAEMORRHAGE 319 0.0215
501 NERVE INJURY 239 0.0215
502 SLUGGISHNESS 219 0.0214
503 HYPERCALCAEMIA 265 0.0214
504 RENAL PAIN 227 0.0214
505 VITREOUS FLOATERS 210 0.0213
506 PNEUMONIA ASPIRATION 533 0.0213
507 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1024 0.0213
508 IMPAIRED QUALITY OF LIFE 306 0.0213
509 BURNING SENSATION 1490 0.0212
510 JOINT DISLOCATION 224 0.0212
511 BLOOD ALKALINE PHOSPHATASE INCREASED 526 0.0212
512 ILEUS 263 0.0211
513 GASTROENTERITIS VIRAL 381 0.0211
514 SPINAL PAIN 247 0.0211
515 CONTRAINDICATED PRODUCT ADMINISTERED 637 0.0210
516 RHINORRHOEA 1358 0.0210
517 DYSPHAGIA 1988 0.0209
518 HOT FLUSH 1577 0.0209
519 ABDOMINAL PAIN UPPER 4297 0.0208
520 DRY THROAT 212 0.0208
521 DYSGEUSIA 1548 0.0208
522 RESPIRATORY ARREST 574 0.0208
523 SPINAL DISORDER 197 0.0208
524 JOINT INJURY 444 0.0208
525 THYROID DISORDER 320 0.0207
526 LOCAL SWELLING 362 0.0207
527 HYPOACUSIS 893 0.0207
528 RESPIRATORY DISTRESS 571 0.0207
529 BLOOD CREATINE PHOSPHOKINASE INCREASED 594 0.0206
530 LIVER FUNCTION TEST ABNORMAL 600 0.0206
531 BODY TEMPERATURE INCREASED 420 0.0206
532 CYST 255 0.0205
533 MIDDLE INSOMNIA 383 0.0205
534 DEPRESSED LEVEL OF CONSCIOUSNESS 811 0.0205
535 NIGHT SWEATS 660 0.0205
536 FOOT DEFORMITY 227 0.0205
537 IMPAIRED HEALING 672 0.0204
538 KIDNEY INFECTION 400 0.0204
539 ABDOMINAL PAIN LOWER 515 0.0203
540 PANCYTOPENIA 1138 0.0203
541 BLINDNESS UNILATERAL 287 0.0203
542 HICCUPS 167 0.0203
543 PARKINSONISM 198 0.0203
544 INJURY 1425 0.0203
545 EAR PAIN 394 0.0202
546 STOMATITIS 1228 0.0202
547 PAIN IN JAW 573 0.0202
548 ABDOMINAL DISCOMFORT 3392 0.0202
549 GLYCOSYLATED HAEMOGLOBIN INCREASED 510 0.0202
550 EYE INFECTION 228 0.0202
551 NEUROPATHY PERIPHERAL 1918 0.0201
552 SKIN CANCER 434 0.0201
553 SCAR 345 0.0201
554 DELUSION 313 0.0201
555 ORAL DISCOMFORT 280 0.0201
556 GLAUCOMA 388 0.0201
557 MUSCLE SPASMS 3675 0.0200
558 SCRATCH 211 0.0200
559 ABDOMINAL PAIN 4653 0.0200
560 BLOOD GLUCOSE DECREASED 960 0.0200
561 SKIN LESION 548 0.0200
562 ULCER 317 0.0199
563 UNEVALUABLE EVENT 1507 0.0199
564 GASTROINTESTINAL INFECTION 178 0.0198
565 CANDIDA INFECTION 335 0.0198
566 MYALGIA 3367 0.0198
567 CEREBRAL INFARCTION 483 0.0197
568 RESPIRATORY TRACT CONGESTION 314 0.0197
569 HAEMORRHAGE 2057 0.0197
570 ABDOMINAL DISTENSION 2053 0.0196
571 PNEUMONITIS 534 0.0196
572 MEMORY IMPAIRMENT 2686 0.0195
573 HERPES ZOSTER 1118 0.0194
574 ACTIVITIES OF DAILY LIVING IMPAIRED 385 0.0194
575 MUSCLE TIGHTNESS 314 0.0194
576 ATAXIA 230 0.0194
577 BLOOD THYROID STIMULATING HORMONE INCREASED 178 0.0193
578 HEAD DISCOMFORT 342 0.0193
579 FRACTURE 365 0.0193
580 GASTROINTESTINAL PAIN 212 0.0192
581 PULMONARY ARTERIAL HYPERTENSION 279 0.0192
582 LABORATORY TEST ABNORMAL 568 0.0192
583 QUALITY OF LIFE DECREASED 258 0.0192
584 ASCITES 565 0.0192
585 NAUSEA 15198 0.0192
586 PNEUMOTHORAX 304 0.0192
587 MYOSITIS 172 0.0191
588 PANCREATITIS 1013 0.0191
589 NODULE 250 0.0191
590 BLOOD BILIRUBIN INCREASED 516 0.0191
591 PRESCRIBED UNDERDOSE 381 0.0191
592 DIPLOPIA 496 0.0191
593 GASTRIC DISORDER 655 0.0191
594 GALLBLADDER DISORDER 340 0.0190
595 CHILLS 2229 0.0190
596 ABSCESS 303 0.0190
597 GAIT INABILITY 634 0.0190
598 WEIGHT INCREASED 4246 0.0189
599 SKIN DISORDER 632 0.0189
600 VASCULITIS 220 0.0189
601 INFLUENZA 2105 0.0189
602 CHOKING 368 0.0188
603 PRODUCT ADMINISTRATION ERROR 381 0.0188
604 NEUTROPHIL COUNT INCREASED 193 0.0188
605 SEPTIC SHOCK 818 0.0188
606 JOINT STIFFNESS 493 0.0188
607 ERECTILE DYSFUNCTION 481 0.0187
608 SWOLLEN TONGUE 585 0.0187
609 ANXIETY 5329 0.0187
610 MEDICATION ERROR 1040 0.0187
611 INSOMNIA 4979 0.0187
612 SPINAL FRACTURE 374 0.0186
613 OROPHARYNGEAL PAIN 1726 0.0186
614 PULMONARY EMBOLISM 1770 0.0186
615 MOBILITY DECREASED 1336 0.0186
616 ABASIA 459 0.0186
617 TREMOR 3080 0.0185
618 PNEUMONIA BACTERIAL 170 0.0185
619 GASTRIC HAEMORRHAGE 213 0.0185
620 BONE PAIN 1084 0.0185
621 NASAL CONGESTION 1087 0.0185
622 BLOOD GLUCOSE INCREASED 3484 0.0185
623 ORAL CANDIDIASIS 243 0.0184
624 VISION BLURRED 2533 0.0184
625 TINNITUS 845 0.0184
626 ANGIOEDEMA 812 0.0183
627 VERTIGO 1117 0.0183
628 NERVOUSNESS 956 0.0183
629 JOINT SWELLING 2204 0.0182
630 AMNESIA 1187 0.0182
631 ARTHRALGIA 7572 0.0182
632 HYPOAESTHESIA 2713 0.0181
633 PROTEINURIA 343 0.0180
634 APHONIA 251 0.0180
635 THIRST 321 0.0179
636 PULMONARY FIBROSIS 344 0.0179
637 TREATMENT NONCOMPLIANCE 979 0.0179
638 PARAESTHESIA 2813 0.0179
639 DEPRESSION 4058 0.0178
640 BRAIN OEDEMA 225 0.0178
641 PRURITUS GENERALISED 385 0.0178
642 BLOOD GLUCOSE FLUCTUATION 194 0.0177
643 PLASMA CELL MYELOMA 690 0.0177
644 WHITE BLOOD CELL COUNT DECREASED 1912 0.0176
645 SPEECH DISORDER 922 0.0176
646 PANCREATITIS ACUTE 393 0.0175
647 SWELLING 1635 0.0175
648 MUSCULOSKELETAL STIFFNESS 1530 0.0174
649 RESTLESSNESS 639 0.0174
650 LUNG INFECTION 271 0.0174
651 PHARYNGEAL OEDEMA 268 0.0174
652 CHOLECYSTECTOMY 199 0.0174
653 PRODUCT DOSE OMISSION 1137 0.0174
654 ACUTE RESPIRATORY DISTRESS SYNDROME 308 0.0174
655 THROMBOCYTOPENIA 1947 0.0174
656 RESPIRATORY TRACT INFECTION 453 0.0174
657 RASH PRURITIC 942 0.0174
658 BLOOD GLUCOSE ABNORMAL 321 0.0174
659 FEELING JITTERY 331 0.0174
660 FEEDING DISORDER 352 0.0173
661 METASTASES TO BONE 284 0.0173
662 TOOTH EXTRACTION 215 0.0173
663 VOMITING 8122 0.0173
664 TRANSAMINASES INCREASED 384 0.0173
665 SOMNOLENCE 3477 0.0173
666 FEELING ABNORMAL 4135 0.0172
667 INCREASED APPETITE 329 0.0172
668 CARDIOVASCULAR DISORDER 437 0.0172
669 FREQUENT BOWEL MOVEMENTS 465 0.0172
670 MOTOR DYSFUNCTION 175 0.0172
671 ARTHROPATHY 952 0.0171
672 HYPOAESTHESIA ORAL 258 0.0171
673 SINUSITIS 1754 0.0171
674 INTESTINAL OBSTRUCTION 645 0.0171
675 COGNITIVE DISORDER 798 0.0171
676 METASTASES TO LIVER 300 0.0171
677 ASPARTATE AMINOTRANSFERASE INCREASED 906 0.0170
678 HEPATIC ENZYME INCREASED 1160 0.0170
679 MULTIPLE ORGAN DYSFUNCTION SYNDROME 482 0.0170
680 PAIN 10440 0.0170
681 SEROTONIN SYNDROME 326 0.0170
682 BACTERIAL INFECTION 316 0.0169
683 ALOPECIA 3313 0.0169
684 INTENTIONAL PRODUCT USE ISSUE 1477 0.0168
685 PREMATURE DELIVERY 268 0.0168
686 SUDDEN DEATH 178 0.0168
687 PARAESTHESIA ORAL 242 0.0168
688 THROAT IRRITATION 752 0.0167
689 LUNG DISORDER 821 0.0167
690 SLEEP DISORDER 1179 0.0167
691 NASOPHARYNGITIS 3079 0.0167
692 BREAST PAIN 178 0.0167
693 KNEE ARTHROPLASTY 350 0.0166
694 METASTASES TO LUNG 192 0.0166
695 BEDRIDDEN 218 0.0166
696 VISUAL IMPAIRMENT 2054 0.0166
697 ALANINE AMINOTRANSFERASE INCREASED 1017 0.0165
698 LACRIMATION INCREASED 500 0.0165
699 MYELODYSPLASTIC SYNDROME 239 0.0165
700 BLISTER 928 0.0165
701 MYOCARDITIS 189 0.0165
702 TEMPERATURE INTOLERANCE 170 0.0165
703 LIP SWELLING 547 0.0164
704 COVID-19 2867 0.0163
705 COLITIS 619 0.0163
706 THERAPY CESSATION 837 0.0163
707 FUNGAL INFECTION 543 0.0163
708 SECRETION DISCHARGE 204 0.0163
709 NEOPLASM 187 0.0163
710 MYOCLONUS 194 0.0163
711 ABNORMAL DREAMS 449 0.0162
712 ACUTE HEPATIC FAILURE 222 0.0162
713 SNEEZING 364 0.0162
714 LIVER FUNCTION TEST INCREASED 348 0.0162
715 MALAISE 7088 0.0161
716 RESPIRATORY DISORDER 483 0.0161
717 MALIGNANT MELANOMA 216 0.0161
718 RASH MACULAR 563 0.0161
719 PRODUCT ODOUR ABNORMAL 168 0.0160
720 EYE PAIN 904 0.0160
721 SKIN INFECTION 179 0.0159
722 CYANOSIS 250 0.0159
723 NIGHTMARE 550 0.0159
724 EYE DISORDER 521 0.0158
725 HEADACHE 9925 0.0158
726 TENDON RUPTURE 195 0.0158
727 DEVICE RELATED INFECTION 243 0.0158
728 VIRAL INFECTION 525 0.0158
729 CONDITION AGGRAVATED 4788 0.0157
730 PHOTOSENSITIVITY REACTION 260 0.0157
731 INTENTIONAL OVERDOSE 1009 0.0157
732 MOVEMENT DISORDER 505 0.0157
733 DERMATITIS CONTACT 179 0.0157
734 SPINAL OPERATION 193 0.0157
735 DRUG TOXICITY 213 0.0156
736 HEPATIC CIRRHOSIS 293 0.0156
737 GAMMA-GLUTAMYLTRANSFERASE INCREASED 345 0.0156
738 HEPATIC FAILURE 469 0.0155
739 IMMUNE SYSTEM DISORDER 205 0.0155
740 BLOOD LACTATE DEHYDROGENASE INCREASED 246 0.0155
741 PREMATURE BABY 467 0.0155
742 TENDONITIS 240 0.0155
743 INSURANCE ISSUE 237 0.0155
744 PANIC ATTACK 564 0.0155
745 PRURITUS 5945 0.0155
746 LYMPHADENOPATHY 546 0.0154
747 COORDINATION ABNORMAL 215 0.0154
748 LOWER LIMB FRACTURE 296 0.0154
749 POISONING 193 0.0153
750 WRONG TECHNIQUE IN DRUG USAGE PROCESS 557 0.0153
751 PRODUCT TASTE ABNORMAL 207 0.0153
752 DEAFNESS 399 0.0152
753 RESPIRATORY DEPRESSION 187 0.0152
754 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1084 0.0152
755 VISUAL ACUITY REDUCED 502 0.0151
756 SWELLING FACE 983 0.0151
757 PHARYNGITIS 187 0.0151
758 IMPAIRED DRIVING ABILITY 171 0.0150
759 COLON CANCER 224 0.0150
760 LEUKOPENIA 748 0.0149
761 PYREXIA 5169 0.0149
762 MUSCULOSKELETAL DISORDER 283 0.0149
763 THERAPEUTIC RESPONSE UNEXPECTED 667 0.0149
764 DIABETIC KETOACIDOSIS 357 0.0148
765 INTENTIONAL PRODUCT MISUSE 1299 0.0148
766 JAUNDICE 399 0.0148
767 DISCOMFORT 903 0.0148
768 DISEASE RECURRENCE 703 0.0148
769 THINKING ABNORMAL 275 0.0147
770 HIP ARTHROPLASTY 226 0.0147
771 MUSCLE RIGIDITY 176 0.0147
772 GLOSSODYNIA 329 0.0147
773 INFECTION 2125 0.0147
774 INFUSION SITE PAIN 189 0.0147
775 DRUG-INDUCED LIVER INJURY 460 0.0146
776 EAR INFECTION 390 0.0146
777 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 801 0.0146
778 RASH PAPULAR 327 0.0146
779 INFLAMMATION 751 0.0145
780 PHOTOPHOBIA 273 0.0145
781 DRUG DOSE OMISSION 2396 0.0145
782 SENSORY DISTURBANCE 232 0.0144
783 ANOREXIA 186 0.0144
784 PARALYSIS 206 0.0144
785 INJECTION SITE EXTRAVASATION 176 0.0142
786 DRY EYE 712 0.0142
787 FEBRILE NEUTROPENIA 946 0.0142
788 COMA 678 0.0142
789 BLINDNESS 579 0.0142
790 APATHY 207 0.0142
791 DISEASE PROGRESSION 1678 0.0142
792 AGITATION 1039 0.0141
793 THERAPY INTERRUPTED 1007 0.0141
794 DISTURBANCE IN ATTENTION 759 0.0141
795 DYSKINESIA 570 0.0140
796 GASTROINTESTINAL DISORDER 1256 0.0140
797 MUSCLE TWITCHING 323 0.0140
798 BRAIN FOG 219 0.0140
799 RASH 6077 0.0139
800 ROAD TRAFFIC ACCIDENT 583 0.0139
801 MENTAL IMPAIRMENT 336 0.0138
802 PRODUCT USE COMPLAINT 217 0.0138
803 PRODUCT DOSE OMISSION IN ERROR 390 0.0138
804 DRUG INTOLERANCE 1329 0.0137
805 FEMUR FRACTURE 426 0.0137
806 EYE SWELLING 511 0.0137
807 BRONCHOSPASM 195 0.0137
808 PROCEDURAL PAIN 379 0.0136
809 CYTOPENIA 167 0.0136
810 RASH GENERALISED 353 0.0136
811 PARANOIA 235 0.0136
812 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 969 0.0136
813 THROAT TIGHTNESS 368 0.0136
814 LYMPHOCYTE COUNT DECREASED 240 0.0136
815 PERITONITIS 281 0.0136
816 PRODUCT SUBSTITUTION ISSUE 781 0.0136
817 HOSPITALISATION 2072 0.0135
818 OSTEONECROSIS OF JAW 332 0.0134
819 ALTERED STATE OF CONSCIOUSNESS 290 0.0134
820 ASTHMA 1511 0.0134
821 SKIN FISSURES 261 0.0133
822 DEPRESSED MOOD 706 0.0133
823 LIVER DISORDER 591 0.0133
824 IMMUNODEFICIENCY 198 0.0133
825 PERICARDITIS 223 0.0133
826 EMOTIONAL DISTRESS 1605 0.0132
827 PRODUCT PHYSICAL ISSUE 267 0.0132
828 ORAL HERPES 258 0.0132
829 ILLNESS 1355 0.0131
830 DRUG DISPENSING ERROR 201 0.0131
831 INTENTIONAL DOSE OMISSION 374 0.0131
832 SEDATION 343 0.0131
833 C-REACTIVE PROTEIN INCREASED 476 0.0131
834 INTRAOCULAR PRESSURE INCREASED 167 0.0131
835 PSORIATIC ARTHROPATHY 529 0.0130
836 DRUG ADMINISTRATION ERROR 399 0.0130
837 INCORRECT PRODUCT ADMINISTRATION DURATION 281 0.0130
838 MOUTH ULCERATION 272 0.0129
839 SARS-COV-2 TEST POSITIVE 170 0.0129
840 PRODUCT QUALITY ISSUE 1745 0.0128
841 ACUTE MYELOID LEUKAEMIA 200 0.0128
842 MULTIPLE FRACTURES 210 0.0128
843 INTENTIONAL DRUG MISUSE 267 0.0128
844 DEVICE OCCLUSION 179 0.0127
845 IRRITABLE BOWEL SYNDROME 272 0.0127
846 PSORIASIS 1656 0.0127
847 HEPATOTOXICITY 282 0.0127
848 RASH ERYTHEMATOUS 605 0.0126
849 RHEUMATOID ARTHRITIS 1436 0.0126
850 DEATH 10880 0.0126
851 DRUG EFFECT INCOMPLETE 458 0.0126
852 INCORRECT DRUG ADMINISTRATION DURATION 354 0.0126
853 ERYTHEMA 2586 0.0126
854 EXPIRED PRODUCT ADMINISTERED 418 0.0126
855 PRODUCT AVAILABILITY ISSUE 285 0.0125
856 TOXIC EPIDERMAL NECROLYSIS 190 0.0125
857 MENTAL DISORDER 544 0.0125
858 OFF LABEL USE 10943 0.0125
859 OCULAR HYPERAEMIA 593 0.0125
860 IMPAIRED WORK ABILITY 267 0.0125
861 INFLUENZA LIKE ILLNESS 1028 0.0125
862 INFUSION RELATED REACTION 827 0.0125
863 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 290 0.0124
864 SUICIDE ATTEMPT 754 0.0124
865 CONVULSION 708 0.0124
866 FOETAL EXPOSURE DURING PREGNANCY 997 0.0123
867 SEIZURE 1406 0.0122
868 NEOPLASM PROGRESSION 423 0.0122
869 PRODUCT USE ISSUE 2276 0.0121
870 PRESCRIBED OVERDOSE 234 0.0121
871 EYE PRURITUS 406 0.0121
872 MALIGNANT NEOPLASM PROGRESSION 1237 0.0121
873 SKIN EXFOLIATION 1014 0.0120
874 DISSEMINATED INTRAVASCULAR COAGULATION 168 0.0119
875 DRUG EFFECT DECREASED 639 0.0119
876 ACCIDENTAL OVERDOSE 433 0.0118
877 ANOSMIA 171 0.0118
878 INJECTION SITE MASS 436 0.0118
879 SURGERY 687 0.0117
880 EYE IRRITATION 673 0.0117
881 EMOTIONAL DISORDER 360 0.0117
882 THERAPEUTIC PRODUCT EFFECT DECREASED 521 0.0116
883 DERMATITIS 243 0.0116
884 LYMPHOMA 179 0.0116
885 HALLUCINATION, AUDITORY 184 0.0116
886 PRODUCT DOSE OMISSION ISSUE 3396 0.0115
887 HYPERSENSITIVITY 2142 0.0115
888 STEVENS-JOHNSON SYNDROME 256 0.0115
889 THERAPY NON-RESPONDER 517 0.0115
890 LUNG NEOPLASM MALIGNANT 472 0.0115
891 DISABILITY 227 0.0115
892 FACE OEDEMA 193 0.0114
893 NERVOUS SYSTEM DISORDER 352 0.0113
894 CONJUNCTIVITIS 207 0.0111
895 MUCOSAL INFLAMMATION 292 0.0111
896 PAIN OF SKIN 300 0.0111
897 NEEDLE ISSUE 323 0.0111
898 LIVER INJURY 272 0.0111
899 URTICARIA 1851 0.0110
900 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1984 0.0110
901 ADVERSE EVENT 1013 0.0110
902 MIGRAINE 1048 0.0110
903 PRODUCT DISPENSING ERROR 239 0.0110
904 GENERALISED TONIC-CLONIC SEIZURE 181 0.0109
905 UNDERDOSE 796 0.0109
906 PRODUCT PRESCRIBING ISSUE 236 0.0108
907 CRYING 388 0.0107
908 BONE DENSITY DECREASED 334 0.0106
909 PSYCHOTIC DISORDER 314 0.0106
910 DRUG INEFFECTIVE 13876 0.0105
911 NEUTROPHIL COUNT DECREASED 428 0.0105
912 ILL-DEFINED DISORDER 637 0.0105
913 DRY SKIN 1393 0.0104
914 ADVERSE DRUG REACTION 937 0.0104
915 TOOTH LOSS 214 0.0103
916 NEOPLASM MALIGNANT 684 0.0102
917 INCORRECT DOSE ADMINISTERED 2326 0.0102
918 PRODUCT USE IN UNAPPROVED INDICATION 2519 0.0102
919 CHOLESTASIS 195 0.0101
920 HEPATITIS 258 0.0101
921 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2038 0.0100
922 NEUTROPENIA 1355 0.0100
923 NEUROTOXICITY 174 0.0099
924 ABNORMAL BEHAVIOUR 377 0.0095
925 DRUG ERUPTION 168 0.0095
926 WITHDRAWAL SYNDROME 396 0.0094
927 ANGER 317 0.0094
928 INJECTION SITE BRUISING 741 0.0093
929 MOOD ALTERED 253 0.0093
930 INTERSTITIAL LUNG DISEASE 449 0.0093
931 INJECTION SITE HAEMORRHAGE 740 0.0093
932 VAGINAL HAEMORRHAGE 401 0.0092
933 CYTOKINE RELEASE SYNDROME 184 0.0092
934 THERAPEUTIC RESPONSE DECREASED 551 0.0091
935 AGGRESSION 449 0.0090
936 OVERDOSE 1924 0.0089
937 DEVICE MALFUNCTION 626 0.0089
938 APPLICATION SITE PRURITUS 201 0.0089
939 IRRITABILITY 532 0.0088
940 APPLICATION SITE ERYTHEMA 229 0.0087
941 MOOD SWINGS 276 0.0086
942 COLITIS ULCERATIVE 387 0.0086
943 BONE MARROW FAILURE 175 0.0086
944 APPLICATION SITE PAIN 189 0.0086
945 LOWER RESPIRATORY TRACT INFECTION 385 0.0085
946 EXPOSURE DURING PREGNANCY 519 0.0083
947 SUICIDAL IDEATION 760 0.0083
948 EXTRA DOSE ADMINISTERED 335 0.0083
949 ANAPHYLACTIC REACTION 456 0.0082
950 PANCREATIC CARCINOMA 235 0.0081
951 RASH MACULO-PAPULAR 181 0.0081
952 OSTEONECROSIS 267 0.0081
953 DEVICE DELIVERY SYSTEM ISSUE 222 0.0081
954 ECZEMA 417 0.0080
955 MULTIPLE SCLEROSIS 381 0.0080
956 DEVICE ISSUE 686 0.0076
957 PHARMACEUTICAL PRODUCT COMPLAINT 197 0.0076
958 INJECTION SITE PRURITUS 507 0.0076
959 MULTIPLE SCLEROSIS RELAPSE 517 0.0075
960 MATERNAL EXPOSURE DURING PREGNANCY 670 0.0075
961 INJECTION SITE PAIN 2305 0.0075
962 THERAPEUTIC RESPONSE SHORTENED 247 0.0074
963 EPILEPSY 221 0.0072
964 ANAPHYLACTIC SHOCK 185 0.0072
965 HEPATIC FUNCTION ABNORMAL 265 0.0071
966 PRODUCT ADHESION ISSUE 253 0.0071
967 INJECTION SITE RASH 216 0.0070
968 TARDIVE DYSKINESIA 195 0.0069
969 SKIN BURNING SENSATION 495 0.0069
970 SYSTEMIC LUPUS ERYTHEMATOSUS 243 0.0068
971 INJECTION SITE ERYTHEMA 842 0.0068
972 INJECTION SITE REACTION 463 0.0067
973 INJECTION SITE SWELLING 501 0.0065
974 SKIN IRRITATION 293 0.0064
975 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 204 0.0060
976 TREATMENT FAILURE 477 0.0058
977 INCORRECT ROUTE OF DRUG ADMINISTRATION 194 0.0054
978 PROSTATE CANCER 404 0.0050
979 NO ADVERSE EVENT 902 0.0050
980 ACNE 377 0.0050
981 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 232 0.0050
982 DRUG WITHDRAWAL SYNDROME 435 0.0050
983 DEVICE DISLOCATION 208 0.0048
984 DEVICE LEAKAGE 204 0.0047
985 BREAST CANCER 435 0.0047
986 DRUG ABUSE 385 0.0046
987 ACCIDENTAL EXPOSURE TO PRODUCT 440 0.0043
988 DERMATITIS ATOPIC 218 0.0041
989 DRUG DOSE OMISSION BY DEVICE 322 0.0041
990 PRODUCT STORAGE ERROR 328 0.0037
991 BLADDER CANCER 214 0.0036
992 RENAL CANCER 169 0.0035
993 DEVICE DIFFICULT TO USE 201 0.0030
994 DRUG DEPENDENCE 360 0.0022